Gastrin: An analytical review

Annals of Clinical Biochemistry

Volumn 40, Issue 5, 2003, Pages 472-480

  Varro, Andrea ^a   Ardill, Joy E S ^b  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ANTIBODY; CHOLECYSTOKININ; CHOLECYSTOKININ RECEPTOR; GASTRIN; GASTRIN RECEPTOR; OCTREOTIDE; PROGASTRIN; PROTON PUMP INHIBITOR;

AMINO ACID SEQUENCE; ANALYTIC METHOD; ATROPHIC GASTRITIS; BIOASSAY; CARCINOID; CELL HYPERPLASIA; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; ENDOCRINE FUNCTION TEST; ENTEROCHROMAFFIN CELL; GASTRIC CARCINOID; GASTRIN BLOOD LEVEL; GASTRINOMA; GASTROINTESTINAL DISEASE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HORMONE ACTION; HORMONE DETERMINATION; HUMAN; HYPERGASTRINEMIA; ISOTOPE LABELING; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; REVIEW; STANDARDIZATION; VALIDATION PROCESS;

ANIMALS; GASTRINS; HUMANS; RADIOIMMUNOASSAY; SENSITIVITY AND SPECIFICITY;

HELICOBACTER; HELICOBACTER PYLORI;

EID: 0141629285     PISSN: 00045632     EISSN: None     Source Type: Journal    
DOI: 10.1258/000456303322326380     Document Type: Review

References (72)

1. Edkins JS. On the chemical mechanism of gastric secretion. Proc Roy Soc Ser B 1905; 76: 376
2. Gregory RA, Tracy HJ. The constitution and properties of two gastrins extracted from hog antral mucosa. Gut 1964; 5: 103-14
3. Gregory RA, Tracy HJ. Isolation of two "big gastrins" from Zollinger-Ellison tumour tissue. Lancet 1972; ii: 797-9
4. Walsh JH. Gastrin. In: Walsh JH, Dockray GJ, eds. Gut Peptides. New York: Raven Press, 1994: 75-121
5. Dockray GJ, Varro A, Dimaline R. Gastric endocrine cells: gene expression, processing, and targeting of active products. Physiol Rev 1996; 76: 767-98
6. Gregory RA, Tracy HJ, Agarwal KL, Grossman MI. Aminoacid constitution of two gastrins isolated from Zollinger-Ellison tumour tissue. Gut 1969; 10: 603-8
7. Rosenquist GL, Walsh JH. Radioimmunoassay of gastrin. In: Jerzy Glass GB, ed. Gastrointestinal Hormones. New York: Raven Press, 1980: 769-95
8. Yalow RS, Berson SA. Radioimmunoassay of gastrin. Gastroenterology 1970; 58: 1-14
9. Hansky J, Cain MD. Radioimmunoassay of gastrin in human serum. Lancet 1969; ii: 1388-90
10. McGuigan JE, Trudeau WL. Immunochemical measurement of elevated levels of gastrin in the serum of patients with pancreatic tumors of the Zollinger-Ellison variety. N Engl J Med 1968; 278: 1308-13
11. Stadil F, Rehfeld JF. Radioimmunoassay of gastrin in human serum. Scand J Gastroenterol Suppl 1971; 9: 61-5
12. Ito R, Sato K, Helmet T, Jay G, Agarwal K. Structural analysis of the gene encoding human gastrin: the large intron contains an Alu sequence. Proc Natl Acad Sci USA 1984; 81: 4662-6
13. Desmond H, Pauwels S, Varro A, Gregory H, Young J, Dockray GJ. Isolation and characterization of the intact gastrin precursor from a gastrinoma. FEBS Lett 1987; 210: 185-8
14. Reeve JR Jr, Walsh JH, Tompkins RK, Hawke D, Shively JE. Amino terminal fragments of human progastrin from gastrinoma. Biochem Biophys Res Commun 1984; 123: 404-9
15. Dockray GJ. Topical review. Gastrin and gastric epithelial physiology. J Physiol 1999; 518: 315-24
16. Seva C, Dickinson CJ, Yamada T. Growth-promoting effects of glycine-extended progastrin. Science 1994; 265: 410-2
17. Singh P, Owlia A, Varro A, Dai B, Rajaraman S, Wood T. Gastrin gene expression is required for the proliferation and tumorigenicity of human colon cancer cells. Cancer Res 1996; 56: 4111-5
18. Wang TC, Koh TJ, Varro A, Cahill RJ, Dangler CA, Fox JG, et al. Processing and proliferative effects of human progastrin in transgenic mice. J Clin Invest 1996; 98: 1918-29
19. Varro A, Henry J, Vaillant C, Dockray GJ. Discrimination between temperature- and brefeldin A-sensitive steps in the sulfation, phosphorylation, and cleavage of progastrin and its derivatives. J Biol Chem 1994; 269: 20764-70
20. Varro A, Voronina S, Dockray GJ. Pathways of processing of the gastrin precursor in rat antral mucosa. J Clin Invest 1995; 95: 1642-9
21. Varro A, Dockray GJ, Bate GW, Vaillant C, Higham A, Armitage E, et al. Gastrin biosynthesis in the antrum of patients with pernicious anemia. Gastroenterology 1997; 112: 733-41
22. Macro JA, Bate GW, Varro A, Vaillant C, Seidah NG, Dimaline R, et al. Regulation by gastric acid of the processing of progastrin-derived peptides in rat antral mucosa. J Physiol 1997; 502: 409-19
23. Gregory RA, Tracy HJ, Harris JI, Runswick MJ, Moore S, Kenner GW, et al. Minigastrin: corrected structure and synthesis. Hoppe Seylers Z Physiol Chem 1979; 360: 73-80
24. Gregory RA, Dockray GJ, Reeve JR Jr, Shively JE, Miller C. Isolation from porcine antral mucosa of a hexapetide corresponding to the C-terminal sequence of gastrin. Peptides 1983; 4: 319-23
25. Rehfeld JF, Johnsen AH. Identification of gastrin component I as gastrin-71. The largest possible bioactive progastrin product. Eur J Biochem 1994; 223: 765-73
26. Nemeth J, Taylor B, Pauwels S, Varro A, Dockray GJ. Identification of progastrin derived peptides in colorectal carcinoma extracts. Gut 1993; 34: 90-5
27. Dockray GJ, Varro A, Dimaline R, Wang T. The gastrins: their production and biological activities. Annu Rev Physiol 2001; 63: 119-39
28. Larsson H, Carlsson E, Mattsson H, Lundell L, Sundler F, Sundell G, et al. Plasma gastrin and gastric enterochromaffinlike cell activation and proliferation. Studies with omeprazole and ranitidine in intact and antrectomized rats. Gastroenterology 1986; 90: 391-9
29. Bordi C, D'Adda T, Azzoni C, Pilato FP, Caruana P. Hypergastrinemia and gastric enterochromaffin-like cells. Am J Surg Pathol 1995; 19 (Suppl 1): S8-19
30. Wang TC, Dangler CA, Chen D, Goldenring JR, Koh T, Raychowdhury R, et al. Synergistic interaction between hypergastrinemia and Helicobacter infection in a mouse model of gastric cancer. Gastroenterology 2000; 118: 36-47
31. Kopin AS, Lee YM, McBride EW, Miller LJ, Lu M, Lin HY, et al. Expression cloning and characterization of the canine parietal cell gastrin receptor. Proc Natl Acad Sci USA 1992; 89: 3605-9
32. Ciccotosto GD, McLeish A, Hardy KJ, Shulkes A. Expression, processing, and secretion of gastrin in patients with colorectal carcinoma. Gastroenterology 1995; 109: 1142-53
33. Hollande F, Imdahl A, Mantamadiotis T, Ciccotosto GD, Shulkes A, Baldwin GS. Glycine-extended gastrin acts as an autocrine growth factor in a nontransformed colon cell line. Gastroenterology 1997; 113: 1576-88
34. Singh P, Xu Z, Dai B, Rajaraman S, Rubin N, Dhruva B. Incomplete processing of progastrin expressed by human colon cancer cells: role of noncarboxyamidated gastrins. Am J Physiol 1994; 266: G459-68
35. Watson SA, Michaeli D, Grimes S, Morris TM, Robinson G, Varro A, et al. Gastrimmune raises antibodies that neutralize amidated and glycine-extended gastrin-17 and inhibit the growth of colon cancer. Cancer Res 1996; 56: 880-5
36. Dockray GJ, Walsh JH. Amino terminal gastrin fragment in serum of Zollinger-Ellison syndrome patients. Gastroenterology 1975; 68: 222-30
37. Dockray GJ, Taylor IL. Heptadecapeptide gastrin: measurement in blood by specific radioimmunoassay. Gastroenterology 1976; 71: 971-7
38. Dockray GJ. Immunochemical studies on big gastrin using NH2-terminal specific antisera. Regul Pept 1980; 1: 169-86
39. van Solinge WW, Rehfeld JF. Radioimmunoassay for sequence 38-54 of human progastrin: increased diagnostic specificity of gastrin-cell diseases. Clin Chim Acta 1990; 192: 35-46
40. Pauwels S, Desmond H, Dimaline R, Dockray GJ. Identification of progastrin in gastrinomas, antrum, and duodenum by a novel radioimmunoassay. J Clin Invest 1986; 77: 376-81
41. Azuma T, Taggart RT, Walsh JH. Effects of bombesin on the release of glycine-extended progastrin (gastrin G) in rat antral tissue culture. Gastroenterology 1987; 93: 322-9
42. Delvalle J, Sugano K, Yamada T. Glycine-extended processing intermediates of gastrin and cholecystokinin in human plasma. Gastroenterology 1989; 97: 1159-63
43. Kovacs TO, Walsh JH, Maxwell V, Wong HC, Azuma T, Katt E. Gastrin is a major mediator of the gastric phase of acid secretion in dogs: proof by monoclonal antibody neutralization. Gastroenterology 1989; 97: 1406-13
44. McGuigan JE. Immunochemical studies with synthetic human gastrin. Gastroenterology 1968; 54: 1005-11
45. Pillai S, Mohimen A, Kanjilal A. A polyethylene glycol-based radioimmunoassay for gastrin. J Immunol Methods 1980; 39: 181-4
46. Schrumpf E, Sand T. Radioimmunoassay of gastrin with activated charcoal. Scand J Gastroenterol 1972; 7: 683-7
47. Dockray GJ, Walsh JH, Grossman MI. Biological activity of iodinated gastrins. Biochem Biophys Res Commun 1976; 69: 339-45
48. Rehfeld JF. NH2-terminal monoiodination of hexadecapeptide gastrin: a simple procedure for preparation of 1251-gastrin for radioimmunoassays and receptors studies. Clin Chim Acta 1980; 101: 271-5
49. Choudhury AM, Kenner GW, Moore S, Ramachandran KL, Thorpe WD, Ramage R, et al. N-Terminal sequence of human big gastrin: sequence, synthetic and immunochemical studies. Hoppe Seylers Z Physiol Chem 1980; 361: 1719-33
50. Pauwels S, Dockray GJ, Walker R, Marcus S. Metabolism of heptadecapeptide gastrin in humans studied by region-specific antisera. J Clin Invest 1985; 75: 2006-13
51. Higashimoto Y, Himeno S, Shinomura Y, Nagao K, Tamura T, Tarui S. Purification and structural determination of urinary NH2-terminal big gastrin fragments. Biochem Biophys Res Commun 1989; 160: 1364-70
52. Roy PK, Venzon DJ, Shojamanesh H, Abou-Saif A, Peghini P, Doppman JL, et al. Zollinger-Ellison syndrome. Clinical presentation in 261 patients. Medicine (Baltimore) 2000; 79: 379-411
53. Hallgren R, Karlsson FA, Lundqvist G. Serum level of immunoreactive gastrin: influence of kidney function. Gut 1978; 19: 207-13
54. Walsh JH, Richardson CT, Fordtran JS. pH dependence of acid secretion and gastrin release in normal and ulcer subjects. J Clin Invest 1975; 55: 462-8
55. Lamberts R, Creutzfeldt W, Struber HG, Brunner G, Solcia E. Long-term omeprazole therapy in peptic ulcer disease: gastrin, endocrine cell growth, and gastritis. Gastroenterology 1993; 104: 1356-70
56. Isenberg JI, Walsh JH, Passaro E Jr, Moore EW, Grossman MI. Unusual effect of secretin on serum gastrin, serum calcium, and gastric acid secretion in a patient with suspected Zollinger-Ellison syndrome. Gastroenterology 1972; 62: 626-31
57. Alexander HR, Bartlett DL, Venzon DJ, Libutti SK, Doppman JL, Fraker DL, et al. Analysis of factors associated with long-term (five or more years) cure in patients undergoing operation for Zollinger-Ellison syndrome. Surgery 1998; 124: 1160-6
58. Cadiot G, Houillier P, Allouch A, Paillard M, Mignon M. Oral calcium tolerance test in the early diagnosis of primary hyperparathyroidism and multiple endocrine neoplasia type 1 in patients with the Zollinger-Ellison syndrome. Groupe de Recherche et d'Etude du Syndrome de Zollinger-Ellison. Gut 1996; 39: 273-8
59. Jais P, Mignon M. Normal serum gastrin concentration in gastrinoma. Lancet 1995; 346: 1421-2
60. Korman MG, John DJ, Hansky J. Studies on serum gastrin levels in pernicious anaemia. Gut 1970; 11: 981
61. Banerjee S, Ardill JE, Beattie AD, McColl KE. Effect of omeprazole and feeding on plasma gastrin in patients with achlorhydria. Aliment Pharmacol Ther 1995; 9: 507-12
62. Hayes JR, Ardill J, Shanks RG, Buchanan KD. Effect of catecholamines on gastrin release. Metabolism 1978; 27: 385-91
63. Peghini PL, Annibale B, Azzoni C, Milione M, Corleto VD, Gibril F, et al. Effect of chronic hypergastrinemia on human enterochromaffin-like cells: insights from patients with sporadic gastrinomas. Gastroenterology 2002; 123: 68-85
64. Hirschowitz BI, Griffith J, Pellegrin D, Cummings OW. Rapid regression of enterochromaffinlike cell gastric carcinoids in pernicious anemia after antrectomy. Gastroenterology 1992; 102: 1409-18
65. Higham AD, Dimaline R, Varro A, Attwood S, Armstrong G, Dockray GJ, et al. Octreotide suppression test predicts beneficial outcome from antrectomy in a patient with gastric carcinoid tumor. Gastroenterology 1998; 114: 817-22
66. Levi S, Beardshall K, Haddad G, Playford R, Ghosh P, Calam J. Campylobacter pylori and duodenal ulcers: the gastrin link. Lancet 1989; i: 1167-8
67. Gillen D, el Omar EM, Wirz AA, Ardill JE, McColl KE. The acid response to gastrin distinguishes duodenal ulcer patients from Helicobacter pylori-infected healthy subjects. Gastroenterology 1998; 114: 50-7
68. Calam J, Gibbons A, Healey ZV, Bliss P, Arebi N. How does Helicobacter pylori cause mucosal damage? Its effect on acid and gastrin physiology. Gastroenterology 1997; 113(suppl.): S43-9
69. Baser MJ, Berg DE. Helicobacter pylori genetic diversity and risk of human disease. J Clin Invest 2001; 107: 767-73
70. Suzuki T, Grand E, Bowman C, Merchant JL, Todisco A, Wang L, et al. TNF-alpha and interleukin 1 activate gastrin gene expression via MAPK- and PKC-dependent mechanisms. Am J Physiol Gastrointest Liver Physiol 2001; 281: G1405-12
71. Koh TJ, Dockray GJ, Varro A, Cahill RJ, Dangler CA, Fox JG, et al. Overexpression of glycine-extended gastrin in transgenic mice results in increased colonic proliferation. J Clin Invest 1999; 103: 1119-26
72. Bardram L, Rehfeld JF. Processing-independent radioimmunoanalysis: a general analytical principle applied to progastrin and its products. Anal Biochem 1988; 175: 537-43